ferric carboxymaltose (intravenous)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ferric carboxymaltose (intravenous), covering 2020-10-19 to 2020-10-19. Get the full timeline:
Most recent: Clinical Trial Update: Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study. [Phase 2]